Shernan Holtan, MD

Medical experts discuss the data that led to belumosudil’s FDA approval.

Medical experts discuss advanced therapies in cGVHD.

Medical experts discuss criteria for switching GVHD treatments and how to choose between available treatment options.

Medical experts discuss overall goals for cGVHD treatment as well as concerns with long-term corticosteroid use in treatment.

Medical experts discuss navigating chronic GVHD.

After a brief introduction, Shernan Holtan, MD, and Haris Ali, MD, discuss the distinction between acute and chronic graft-vs-host disease.